The University’s Health System reached an agreement with Bon Secours Health System last week to expand its clinical programs and add new health services in the Richmond and Charlottesville areas.
The collaboration seeks to provide services for interventional neuroradiology, pediatric infectious diseases, pediatric genetics and heart care.
Bon Secours and the University have partnered in the past to provide top health care services.
“Our existing partnerships were designed to expand access to high-quality specialty care,” Medical Center spokesperson Eric Swensen said. “The agreement signed this week looks to build on the success of those partnerships to enhance care for patients throughout Virginia.”
Since the agreement is non-exclusive, both health systems are allowed to pursue additional partnerships with other healthcare providers.
“Both U.Va. and Bon Secours saw an opportunity to collaborate to expand access to high-quality, specialized care for patients across Virginia as well as share best practices in patient safety and care coordination,” Swensen said.
The partnership will also allow for the health systems to launch initiatives that will improve “heart care, cancer care and clinical trials, patient safety, enhancing the physician recruitment pipeline and population health,” according to a University press release.
Additionally, the partnership will add to the Medical School’s academic affiliation with Bon Secours, which allows medical students to complete clinical rotations in Bon Secours health facilities in the area.
“This expanded relationship with U.Va. will help us identify additional opportunities for collaboration to better serve our patients and our community,” said Peter J. Bernard, CEO of Bon Secours Virginia Health System, in the press release. “This agreement will help increase coordination and enhance transitions of care between Bon Secours and UVA care providers.”
Read More
U.Va. researchers identify that HIV drugs can protect against Alzheimer’s disease
By Lauren Seeliger | YesterdayDoctor Jayakrishna Ambati and his research team have begun work on a new drug called K9 which could treat and prevent Alzheimer’s.
Graduating students share their future plans as they enter the job market
By Nina Broderick | 2 days agoMany students find the Career Center to be a valuable tool during the job search and application process.
U.Va.’s Finals Weekend spotlights the achievement and service of the Class of 2025
By Leigh Bailey | 4 days agoIn University President Jim Ryan’s welcome address, he acknowledged the support of family members and friends present in the audience and beyond that played supportive roles in these graduates’ lives.
